Efficacy of prolotherapy and arthrocentesis in management of temporomandibular joint hypermobility

ArticleAçık Erişim

Özet

Objective: The aim of this study was to compare the efficacy of dextrose prolotherapy in conjunction with arthrocentesis and dextrose prolotherapy alone in the management of symptomatic TMJ hypermobility. Methods: Twenty-four patients suffering from TMJ symptomatic hypermobility received 10% dextrose injections for three sessions at four-week intervals. Twelve patients (P group) received prolotherapy alone; the other 12 (PA group) also underwent a single arthrocentesis session. Patients were evaluated for maximal incisal opening, maximal incisal opening without pain, pain at rest, pain during chewing function, TMJ sound, and locking episode frequency. Results: Pain scores were significantly reduced in both groups, and the locking episode frequency was decreased to a greater extent in the PA than the P group, at both the short and long terms. Conclusion: Prolotherapy is effective in the management of TMJ hypermobility. However, prolotherapy with arthrocentesis may be superior to prolotherapy alone in the management of TMJ hypermobility. © 2020 Taylor & Francis Group, LLC.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/12421Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorTaşkesen, Fatih
dc.contributor.authorCezairli, Burak
dc.date.accessioned2026-10-18T20:27:19.427201493Z
dc.date.available2026-10-18T20:27:19.427201493Z
dc.date.issued2023
dc.description.abstractObjective: The aim of this study was to compare the efficacy of dextrose prolotherapy in conjunction with arthrocentesis and dextrose prolotherapy alone in the management of symptomatic TMJ hypermobility. Methods: Twenty-four patients suffering from TMJ symptomatic hypermobility received 10% dextrose injections for three sessions at four-week intervals. Twelve patients (P group) received prolotherapy alone; the other 12 (PA group) also underwent a single arthrocentesis session. Patients were evaluated for maximal incisal opening, maximal incisal opening without pain, pain at rest, pain during chewing function, TMJ sound, and locking episode frequency. Results: Pain scores were significantly reduced in both groups, and the locking episode frequency was decreased to a greater extent in the PA than the P group, at both the short and long terms. Conclusion: Prolotherapy is effective in the management of TMJ hypermobility. However, prolotherapy with arthrocentesis may be superior to prolotherapy alone in the management of TMJ hypermobility. © 2020 Taylor & Francis Group, LLC.
dc.identifier.doi10.1080/08869634.2020.1861887
dc.identifier.eissn2151-0903
dc.identifier.endpage431
dc.identifier.issn0886-9634
dc.identifier.issue5
dc.identifier.pmid33326351
dc.identifier.scopus2-s2.0-85097597220
dc.identifier.startpage423
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/12421
dc.identifier.volume41
dc.identifier.wosWOS:000599353400001
dc.language.isoen
dc.publisherTaylor and Francis Ltd.
dc.relation.ispartofCranio - Journal of Craniomandibular and Sleep Practice
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectarthrocentesis
dc.subjectProlotherapy
dc.subjecttemporomandibular joint
dc.subjectGlucose
dc.subjectHumans
dc.subjectInjections, Intra-Articular
dc.subjectPain
dc.subjectRange of Motion, Articular
dc.subjectTemporomandibular Joint Disorders
dc.subjectTreatment Outcome
dc.subjecthuman
dc.subjectintraarticular drug administration
dc.subjectrange of motion
dc.subjecttemporomandibular joint disorder
dc.titleEfficacy of prolotherapy and arthrocentesis in management of temporomandibular joint hypermobility
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus10
rdl.citation.wos11
rdl.departmentDepartment of Oral and Maxillofacial Surgery, Faculty of Dentistry, Erzincan Binali Yildirim University, Erzincan, Turkey.
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)